$CLVS A common theme in bioscience investing is that a stock tends to rally vigorously following a strong data release. Thereafter, it can either appreciate further, trade sideways or recede southbound. As such, you need to determine where the stock is heading after a large "pop." If you've been following my work, you'd see that I employ a technique coined high probability event forecasting. As the evolution of my drug approval and clinical outcomes forecasting, high probability event analysis spotted out the Clovis Oncology (CLVS) mega rally. Essentially, it gives you a sense of where your stock will trade going forward.